Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 7:10:1074537.
doi: 10.3389/fcell.2022.1074537. eCollection 2022.

Editorial: Neuroinflammation in acquired epilepsy

Affiliations
Editorial

Editorial: Neuroinflammation in acquired epilepsy

Jianxiong Jiang et al. Front Cell Dev Biol. .
No abstract available

Keywords: BDNF; NADPH oxidase; biomarker; brain infection; epileptogenesis; oxidative stress; reactive oxygen species.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Neuroinflammation in acquired epilepsy

Similar articles

Cited by

References

    1. Allendorfer J. B., Bamman M. M. (2018). Getting the brain into shape: Exercise in neurological disorders. Clin. Ther. 40, 6–7. 10.1016/j.clinthera.2017.12.003 - DOI - PubMed
    1. Devinsky O., Vezzani A., O'Brien T. J., Jette N., Scheffer I. E., de Curtis M., et al. (2018). Epilepsy. Nat. Rev. Dis. Prim. 4, 18024. 10.1038/nrdp.2018.24 - DOI - PubMed
    1. Galanopoulou A. S., Loscher W., Lubbers L., O'Brien T. J., Staley K., Vezzani A., et al. (2021). Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop. Epilepsia Open 6, 276–296. 10.1002/epi4.12490 - DOI - PMC - PubMed
    1. Janmohamed M., Brodie M. J., Kwan P. (2020). Pharmacoresistance - epidemiology, mechanisms, and impact on epilepsy treatment. Neuropharmacology 168, 107790. 10.1016/j.neuropharm.2019.107790 - DOI - PubMed
    1. Korgaonkar A. A., Li Y., Sekhar D., Subramanian D., Guevarra J., Swietek B., et al. (2020). Toll-like receptor 4 signaling in neurons enhances calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor currents and drives post-traumatic epileptogenesis. Ann. Neurol. 87, 497–515. 10.1002/ana.25698 - DOI - PMC - PubMed

Publication types